Results 121 to 130 of about 9,994 (168)
Some of the next articles are maybe not open access.

Galantamine

Drugs, 2012
Goa Karen L, Scott Lesley J, L J Scott
exaly   +5 more sources

Synthesis and Pharmacology of Galantamine

Chemical Reviews, 2005
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Marco-Contelles, J   +4 more
openaire   +3 more sources

Galantamine

Reactions Weekly, 2018
Tian-Tian Lei, Jin-Hua Wang, Guan-Hua Du
openaire   +2 more sources

Galantamine for Alzheimer's disease

2004
Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor.To assess the clinical effects of galantamine in patients with probable or possible Alzheimer's disease (AD), and potential moderators of effect.The trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement ...
C, Loy, L, Schneider
openaire   +2 more sources

Indicators of neuroprotection with galantamine

Brain Research Bulletin, 2005
Alzheimer's disease is pathologically characterized by neurofibrillary tangles and beta-amyloid plaques. These observations form the basis for a large number of disease-modifying therapeutic approaches, which might ultimately lead to neuroprotection and enhanced survival of neurons. Recent data suggest a role for cholinergic stimulation, especially the
openaire   +2 more sources

Home - About - Disclaimer - Privacy